Meridian Life Sciences Tag

A look into Vybion

By: Maureen Newman, UVC Biomedical Engineering Community Connector [caption id="attachment_2970" align="alignleft" width="217"] Courtesy of Vybion[/caption] With a strong history in investigational new drug (IND) enabling processes, Lee Henderson, PhD, President/CEO/Chairman/Founder of Vybion, is no stranger to the world of drug discovery and the formality of clinical trials. Currently, Vybion is 18 months from leaving preclinical studies to enter clinical trials for INT41, which is an Gene Therapy...

Read More